AKT1 and cancer: miR-409 serves as a newly discovered manager in multiple types of cancer which directly targeting radixin to depress tumor cell metastasis and invasion in gastric cancer [37], also functions as a tumor suppressor in non-small-cell lung cancer (NSCLC) through PI3K/AKT pathway by directly targeting SPIN1 [38].